SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
3.890
-0.110 (-2.75%)
At close: May 19, 2026, 4:00 PM EDT
3.850
-0.040 (-1.03%)
After-hours: May 19, 2026, 5:59 PM EDT
SeaStar Medical Holding Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SeaStar Medical Holding stock has a consensus rating of "Buy" and an average price target of $10. The average 1-year stock price forecast is 157.07% higher than the current stock price, while the lowest is $8.00 (+105.66%) and the highest is $12 (+208.48%).
Price Target: $10 (+157.07%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for SeaStar Medical Holding is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +105.66% | May 14, 2026 |
| Maxim Group | Maxim Group | Strong Buy Initiates $1,250 | Strong Buy | Initiates | $1,250 | +32,033.68% | Apr 20, 2023 |
Financial Forecast
Revenue This Year
1.89M
from 1.23M
Increased by 53.00%
Revenue Next Year
2.83M
from 1.89M
Increased by 50.00%
EPS This Year
-3.28
from -5.86
EPS Next Year
-2.09
from -3.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1M | 3.2M | |
| Avg | 1.9M | 2.8M | |
| Low | 1.7M | 2.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.2% | 66.8% | |
| Avg | 53.0% | 50.0% | |
| Low | 38.0% | 35.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.09 | -1.74 | |
| Avg | -3.28 | -2.09 | |
| Low | -3.49 | -2.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.